Background/Objectives: Mild behavioral impairment (MBI) is an early marker of Alzheimer’s disease (AD) and other neurodegenerative diseases, often preceding cognitive decline. The MBI Checklist (MBI-C) is a 34-item tool designed to detect MBI. This study aimed to assess the psychometric properties of the Greek version of the MBI-C and its ability to differentiate patients with mild cognitive impairment due to AD (MCI-AD) from cognitively unimpaired older adults (healthy participants, HPs). Methods: A total of 181 participants (104 MCI-AD, 77 HPs) were recruited from the Third Age Day Care Center IASIS (2019–2023), accompanied by a close informant. Participants underwent neuropsychological assessment [Mini-Mental State Examination (MMSE), Addenbrooke’s Cognitive Examination-Revised (ACE-R)], and informants completed the MBI-C. Internal consistency was evaluated using Cronbach’s α and known-group validity was assessed via comparing MBI-C between the MCI-AD and HPs groups. Diagnostic accuracy was determined via receiver operating characteristic (ROC) analysis. Results: The Greek MBI-C showed excellent internal consistency (Cronbach’s α = 0.899). Among its domains, impulse dyscontrol demonstrated the highest reliability (α = 0.901), whereas decreased motivation (α = 0.564) and abnormal perception/thought content (α = 0.617) exhibited lower reliability. MBI-C total and domain scores were significantly higher in patients with MCI-AD than HPs (p < 0.001). The area under the curve (AUC) was 0.871 (optimal cutoff = 9.5), indicating excellent diagnostic performance. Conclusions: Overall, the Greek MBI-C has strong psychometric properties for MCI-AD. Sociocultural factors might influence symptom identification and reporting, particularly in the domains of decreased motivation and abnormal perception/thought content. Future research should investigate its predictive value for dementia conversion and its applicability to other populations, including individuals with subjective cognitive decline and non-AD causes of MCI.
The Benson Complex Figure Test (BCFT) is a neuropsychological tool designed to assess visuospatial construction and visual memory with lower complexity than traditional tests. This study evaluated its ability to differentiate between major dementia subtypes. In a retrospective cross-sectional analysis of 1428 participants from a Greek third-age day center (healthy participants [Controls]; patients diagnosed with Alzheimer’s disease dementia [ADD], Lewy body dementia [LBD], Frontotemporal dementia [FTD: behavioral variant (BV), non-fluent variant (NFV), semantic variant (SV)], Corticobasal dementia [CBD], Parkinson’s disease dementia [PDD], and mixed Cardiovascular dementia with Alzheimer’s disease [CVD/AD]), all participants completed the BCFT and the Mini-Mental State Examination (MMSE). Multinomial logistic regression, adjusted for age, sex, and education, revealed distinct BCFT profiles across dementia subtypes. Patients with CBD showed significantly lower copy scores than those with ADD (p = 0.006). The FTD-NFV group exhibited superior memory scores compared to all other dementia subtypes (p < 0.001). Poorer BCFT recognition performance was strongly associated with diagnoses of ADD (OR = 0.39, p = 0.012), FTD-BV (OR = 0.22, p = 0.025), and PDD (OR = 0.26, p < 0.001). Classification accuracy was highest for controls and ADD (sensitivity > 89%) but low for rarer subtypes (<25%), partly reflecting sample size limitations. In conclusion, the BCFT captures distinct visuospatial and memory profiles across dementia syndromes, supporting its potential utility in differential diagnosis, particularly for common subtypes such as ADD. Its simpler design may facilitate assessment in older adults, although validation in larger and more balanced cohorts is required for rarer dementias.
About Me
My research interest is neuropsychology tools in dementia
My research interest is neuropsychology tools in dementia